310 related articles for article (PubMed ID: 33975551)
1. The clinical features and prognosis of patients with mucinous breast carcinoma compared with those with infiltrating ductal carcinoma: a population-based study.
Zhou X; Zheng Z; Li Y; Zhao W; Lin Y; Zhang J; Sun Q
BMC Cancer; 2021 May; 21(1):536. PubMed ID: 33975551
[TBL] [Abstract][Full Text] [Related]
2. Clinical Nomogram for Predicting Survival Outcomes in Early Mucinous Breast Cancer.
Fu J; Wu L; Jiang M; Li D; Jiang T; Hong Z; Wang F; Li S
PLoS One; 2016; 11(10):e0164921. PubMed ID: 27760180
[TBL] [Abstract][Full Text] [Related]
3. Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010-2014.
Schroeder MC; Rastogi P; Geyer CE; Miller LD; Thomas A
Oncologist; 2018 Apr; 23(4):481-488. PubMed ID: 29330212
[TBL] [Abstract][Full Text] [Related]
4. Survival outcomes of metaplastic breast cancer patients: results from a US population-based analysis.
Nelson RA; Guye ML; Luu T; Lai LL
Ann Surg Oncol; 2015 Jan; 22(1):24-31. PubMed ID: 25012264
[TBL] [Abstract][Full Text] [Related]
5. Outcome of pure mucinous breast carcinoma compared to infiltrating ductal carcinoma: a population-based study from China.
Cao AY; He M; Liu ZB; Di GH; Wu J; Lu JS; Liu GY; Shen ZZ; Shao ZM
Ann Surg Oncol; 2012 Sep; 19(9):3019-27. PubMed ID: 22451233
[TBL] [Abstract][Full Text] [Related]
6. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
Di Saverio S; Gutierrez J; Avisar E
Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
[TBL] [Abstract][Full Text] [Related]
7. Difference in characteristics and outcomes between medullary breast carcinoma and invasive ductal carcinoma: a population based study from SEER 18 database.
Wang XX; Jiang YZ; Liu XY; Li JJ; Song CG; Shao ZM
Oncotarget; 2016 Apr; 7(16):22665-73. PubMed ID: 27009810
[TBL] [Abstract][Full Text] [Related]
8. Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer.
Jung SY; Kim HY; Nam BH; Min SY; Lee SJ; Park C; Kwon Y; Kim EA; Ko KL; Shin KH; Lee KS; Park IH; Lee S; Kim SW; Kang HS; Ro J
Breast Cancer Res Treat; 2010 Apr; 120(3):627-37. PubMed ID: 20143153
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic characteristics at diagnosis and the survival of patients with medullary breast carcinoma in China: a comparison with infiltrating ductal carcinoma-not otherwise specified.
Cao AY; He M; Huang L; Shao ZM; Di GH
World J Surg Oncol; 2013 Apr; 11():91. PubMed ID: 23607710
[TBL] [Abstract][Full Text] [Related]
10. Invasive micropapillary carcinoma of the breast has a better long-term survival than invasive ductal carcinoma of the breast in spite of its aggressive clinical presentations: a comparison based on large population database and case-control analysis.
Chen H; Wu K; Wang M; Wang F; Zhang M; Zhang P
Cancer Med; 2017 Dec; 6(12):2775-2786. PubMed ID: 29072365
[TBL] [Abstract][Full Text] [Related]
11. Comparative prognostic analysis for triple-negative breast cancer with metaplastic and invasive ductal carcinoma.
Li Y; Zhang N; Zhang H; Yang Q
J Clin Pathol; 2019 Jun; 72(6):418-424. PubMed ID: 30872384
[TBL] [Abstract][Full Text] [Related]
12. Overall Survival of Men and Women With Breast Cancer According to Tumor Subtype: A Population-based Study.
Leone J; Zwenger AO; Leone BA; Vallejo CT; Leone JP
Am J Clin Oncol; 2019 Feb; 42(2):215-220. PubMed ID: 30499840
[TBL] [Abstract][Full Text] [Related]
13. Pure mucinous carcinoma of the breast: clinicopathologic characteristics and long-term outcome among Taiwanese women.
Tseng HS; Lin C; Chan SE; Chien SY; Kuo SJ; Chen ST; Chang TW; Chen DR
World J Surg Oncol; 2013 Jun; 11():139. PubMed ID: 23768133
[TBL] [Abstract][Full Text] [Related]
14. The longitudinal risk of mortality between invasive ductal carcinoma and metaplastic breast carcinoma.
Wu SG; Yang SP; Zhang WW; Wang J; Lian CL; Chen YX; He ZY
Sci Rep; 2020 Dec; 10(1):22070. PubMed ID: 33328559
[TBL] [Abstract][Full Text] [Related]
15. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.
Zhao H
Breast Cancer; 2021 Jan; 28(1):187-195. PubMed ID: 32812198
[TBL] [Abstract][Full Text] [Related]
16. Metaplastic breast cancer: clinicopathological features and its prognosis.
Lee H; Jung SY; Ro JY; Kwon Y; Sohn JH; Park IH; Lee KS; Lee S; Kim SW; Kang HS; Ko KL; Ro J
J Clin Pathol; 2012 May; 65(5):441-6. PubMed ID: 22412048
[TBL] [Abstract][Full Text] [Related]
17. Metaplastic Breast Carcinoma: Clinicopathologic Features and Recurrence Score Results From a Population-based Database.
McMurtry V; Cleary AS; Ruano AL; Lomo L; Gulbahce HE
Am J Clin Oncol; 2023 Dec; 46(12):559-566. PubMed ID: 37705411
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological characteristics and prognosis of mucinous breast carcinoma.
Zhang M; Teng XD; Guo XX; Zhao JS; Li ZG
J Cancer Res Clin Oncol; 2014 Feb; 140(2):265-9. PubMed ID: 24305754
[TBL] [Abstract][Full Text] [Related]
19. Predictors for Survival and Distribution of 21-Gene Recurrence Score in Patients With Pure Mucinous Breast Cancer: A SEER Population-Based Retrospective Analysis.
Ding S; Wu J; Lin C; Chen W; Li Y; Shen K; Zhu L
Clin Breast Cancer; 2019 Feb; 19(1):e66-e73. PubMed ID: 30396812
[TBL] [Abstract][Full Text] [Related]
20. Mucinous Carcinoma of the Breast: Clinicopathological Features and Long-term Prognosis in Comparison with Invasive Ductal Cancer; A Single Hospital's 30+-Year Experience.
Isozaki H; Yamamoto Y; Sakai K; Sho T; Ishihara K; Murakami S; Matsumoto S; Takama T
Acta Med Okayama; 2020 Apr; 74(2):137-143. PubMed ID: 32341588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
